{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T17:13:57Z","timestamp":1774545237615,"version":"3.50.1"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Hemodialysis patients are at increased risk for hepatitis E virus (HEV) infection due to their immunocompromised status and frequent exposure to invasive medical procedures. HEV can lead to chronic infections and severe complications, particularly in high-risk populations. This study aimed to determine HEV-IgG seroprevalence among hemodialysis patients in Ankara, Turkey, and evaluate associated risk factors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 160 hemodialysis patients from three private dialysis centers in Ankara were included in this prospective, cross-sectional study. Anti-HEV-IgG antibodies were detected using the ELISA method. Demographic characteristics and potential risk factors, including dialysis duration, comorbidities, blood transfusion history, drinking water source, dietary habits, and involvement in animal husbandry, were assessed via structured surveys. Statistical analyses were conducted using SPSS Version 22.0, with Pearson\u2019s chi-square and Fisher\u2019s exact tests applied to categorical variables. Logistic regression analysis was performed to identify independent risk factors for HEV seropositivity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>HEV-IgG seropositivity was detected in 42 patients (26.25%). Seroprevalence increased significantly with age, rising from 6.7% in patients under 55\u202fyears to 47.4% in those over 65\u202fyears (<jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.001). Extended dialysis duration (&amp;gt;5\u202fyears) was also significantly associated with HEV seropositivity (<jats:italic>p<\/jats:italic>\u202f=\u202f0.02). However, no significant associations were found between HEV seropositivity and gender, blood transfusion history, source of drinking water, consumption of raw meat, or involvement in animal husbandry (<jats:italic>p<\/jats:italic>\u202f&amp;gt;\u202f0.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The HEV-IgG seroprevalence among hemodialysis patients in Ankara was higher than previously reported rates in Turkey. Age and prolonged dialysis duration emerged as significant risk factors, underscoring the importance of screening and preventive strategies in this vulnerable population. Further multi-regional studies are needed to better understand HEV transmission dynamics and improve management strategies in hemodialysis patients.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2025.1574361","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T04:11:01Z","timestamp":1746763861000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Investigation of hepatitis E virus seroprevalence and risk factors in hemodialysis patients"],"prefix":"10.3389","volume":"13","author":[{"given":"Hakk\u0131","family":"\u00d6zt\u00fcrk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Metin","family":"\u00d6zsoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ay\u015feg\u00fcl","family":"Tuna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Artuner","family":"Varl\u0131ba\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salih","family":"Cesur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Altan","family":"Aksoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayd\u0131n","family":"\u00c7ifci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Emin","family":"Demir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,9]]},"reference":[{"key":"ref1","first-page":"2280","article-title":"Hepatitis E virus","volume-title":"Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 9th ed. Philadelphia, PA: Elsevier.","author":"Trivedi","year":"2020"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e228","DOI":"10.1016\/j.ijid.2012.11.026","article-title":"Hepatitis E virus: the current scenario","volume":"17","author":"Kumar","year":"2013","journal-title":"Int J Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1056\/NEJMoa061847","article-title":"Safety and efficacy of a recombinant hepatitis E vaccine","volume":"356","author":"Shrestha","year":"2007","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"500","DOI":"10.16899\/jcm.1086031","article-title":"Investigating the hepatitis E seroprevalence rates among hemodialysis patients in Turkey with pool analyses method","volume":"12","author":"M\u0131zrak\u00e7\u0131","year":"2022","journal-title":"J Contemp Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.01419","article-title":"Molecular biology and infection of hepatitis E virus","volume":"7","author":"Nan","year":"2016","journal-title":"Front Microbiol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/j.1440-1746.2007.04913.x","article-title":"Hepatitits E virus infection and fulminant hepatic failure during pregnancy","volume":"22","author":"Jilani","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"229","DOI":"10.4103\/1319-3767.56094","article-title":"Natural course of fulminant hepatic failure: the scenario in Bangladesh and the differences from the west","volume":"15","author":"Alam","year":"2009","journal-title":"Saudi J Gastroenterol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3851\/IMP2705","article-title":"Hepatitis E: when to treat and how to treat","volume":"19","author":"Abbas","year":"2014","journal-title":"Antivir Ther"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/9838041","article-title":"Hepatitis E virus in industrialized countries: the silent threat","volume":"2016","author":"Clemente-Casares","year":"2016","journal-title":"Biomed Res Int"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"869","DOI":"10.3390\/ijms18040869","article-title":"Hepatitis E virus genotypes and evolution: emergence of camel hepatitis E variants","volume":"18","author":"Sridhar","year":"2017","journal-title":"Int J Mol Sci"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"a031880","DOI":"10.1101\/cshperspect.a031880","article-title":"Classification and genomic diversity of Enterically transmitted hepatitis viruses","volume":"8","author":"Smith","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/1744-9987.13507","article-title":"Seroepidemiology of hepatitis E virus infection in patients undergoing maintenance hemodialysis: systematic review and meta-analysis","volume":"25","author":"Tavakoli","year":"2020","journal-title":"Ther Apher Dial"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens12050667","article-title":"Hepatitis E virus (HEV) infection in hemodialysis patients: a multicenter epidemiological cohort study in north-eastern Greece","volume":"12","author":"Kogias","year":"2023","journal-title":"Pathogens"},{"key":"ref14","first-page":"59","article-title":"Review of hepatitis E virus Seroprevalence studies in Turkey","volume":"4","author":"Alkan","year":"2022","journal-title":"Dent MedJ R"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.3390\/pathogens12101208","article-title":"Hepatitis E virus (HEV) infection among hemodialysis patients from southern Bulgaria","volume":"12","author":"Kevorkyan","year":"2023","journal-title":"Pathogens"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s1","article-title":"Seroepidemiology of hepatitis E in patients on haemodialysis in Croatia","volume":"52","author":"Mrzljak","year":"2020","journal-title":"Int Urol Nephrol"},{"key":"ref17","first-page":"142","article-title":"Hepatitis E virus Seroprevalence in hemodialysis patients","volume":"2","author":"Kaleli","year":"1999","journal-title":"Viral Hepatitis J"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/(SICI)1096-9071(199801)54:1<38::AID-JMV6>3.0.CO;2-Q","article-title":"Prevalence of antibodies to hepatitis E virus among hemodialysis patients in Sweden","volume":"54","author":"Sylvan","year":"1998","journal-title":"J Med Virol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/s0140-6736(94)92232-2","article-title":"High prevalence of hepatitis E virus antibody in haemodialysis patients","volume":"344","author":"Halfon","year":"1994","journal-title":"Lancet"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"568","DOI":"10.3390\/pathogens9070568","article-title":"Seroprevalence of hepatitis E virus in forestry workers from Trentino-Alto Adige region (northern Italy)","volume":"9","author":"Monini","year":"2020","journal-title":"Pathogens"},{"key":"ref21","first-page":"80","article-title":"Investigation of hepatitis E virus antibodies in sera obtained from hemodialysis patient and healthy donors","volume":"21","author":"K\u0131l\u0131\u00e7","year":"1999","journal-title":"Erciyes T\u0131p Dergisi"},{"key":"ref22","article-title":"Hatay'da hemodiyaliz tedavisi alan hastalarda hepatit e virus seropozitifli\u011fi","volume":"43","author":"U\u00e7ar","year":"2009","journal-title":"Mikrobiyol Bul"},{"key":"ref23","first-page":"227","article-title":"Prevalence of hepatitis E virus (HEV) antibody in hemodialysis patients","volume":"30","author":"Sezer","year":"1996","journal-title":"Mikrobiyol B\u00fclt"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1111\/apt.14285","article-title":"Systematic review with meta-analysis: the association between hepatitis E seroprevalence and haemodialysis","volume":"46","author":"Haffar","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1159\/000294505","article-title":"Hepatitis E virus infection: a general review with a focus on hemodialysis and kidney transplant patients","volume":"31","author":"Hosseini-Moghaddam","year":"2010","journal-title":"Am J Nephrol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12941-018-0269-6","article-title":"Hepatitis E virus infection in Turkey: a systematic review","volume":"17","author":"Leblebicioglu","year":"2018","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"ref27","first-page":"41","article-title":"Hemodiyaliz hastalar\u0131nda HEV ve HCV enfeksiyonlar\u0131 aras\u0131ndaki ili\u015fkinin ara\u015ft\u0131r\u0131lmas\u0131. T\u00fcrk Nefroloji Diyaliz ve Transplantasyon Derg","volume":"10","author":"Bozday\u0131","year":"2001"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1159\/000349888","article-title":"Chronic hepatitis E infection: risks and controls","volume":"56","author":"Parvez","year":"2013","journal-title":"Intervirology"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1574361\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T04:11:03Z","timestamp":1746763863000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1574361\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":28,"alternative-id":["10.3389\/fpubh.2025.1574361"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2025.1574361","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,9]]},"article-number":"1574361"}}